Inveready

Quick read

Inveready, a multi-stage alternative asset manager, was founded in 2008 and is headquartered in San Sebastián, Spain, with offices in Barcelona and Madrid. It manages €2.6bn+ across 35+ funds spanning early-stage VC, growth equity, venture debt, biotech, private equity, and infrastructure. Portfolio highlights include exits to Intel, IBM, Symantec, and Facebook, plus 15 IPOs on NASDAQ, BME Growth, AIM London, and Euronext Growth.

Key facts

Founded

2008

Employees

60

Sectors

biotech, enterprise, healthcare, fintech, ai, generalist

Website

inveready.com

Investment thesis

Inveready backs companies across their full lifecycle — from early-stage VC and biotech through growth equity, venture debt, and public markets — concentrating on the small and mid-market segment in Southern Europe. The firm pairs direct equity strategies with debt instruments to support founders from seed to IPO or acquisition.

Recent activity

• May 2026investment
  Inveready's latest recorded investment was in Dolfin, a financial software company, on 13 May 2026. pitchbook.com
• Jun 2025fundraise
  Inveready and Terram Capital announced a partnership to launch Terram Inveready Credit Partners, a new private debt platform targeting a €200m asset-based fund in 2026. es.linkedin.com
• Jun 2025fundraise
  Inveready closed the Inveready Innvierte fund, announced via LinkedIn by team member Antonio H. linkedin.com
• Sep 2025investment
  Inveready subscribed to Hoffmann Green Cement Technologies' convertible bond issue for €6 million. tracxn.com
• Aug 2025investment
  Inveready participated in Ucademy's €3.5m funding round alongside BS Capital Group. tracxn.com
• 2025investment
  Inveready Life Sciences led the seed round of Iteria Biopharma, a Galicia-based biotech specialising in drugs for advanced metastatic cancers unresponsive to current treatments. es.linkedin.com
• 2025product
  An Inveready-backed drug received its first regulatory approval — flagged internally as the firm's most profitable life sciences investment by multiple and IRR. es.linkedin.com
• 2025press
  CEO and Managing Partner Josep Ma Echarri spoke at Inside Deals by Kreab España alongside KPMG España. es.linkedin.com

Notable investments

• DolfinundisclosedMay 2026pitchbook.com
• Iteria BiopharmaSeed2025es.linkedin.com
• UcademyundisclosedAug 2025tracxn.com
• Hoffmann Green Cement TechnologiesConvertible BondSep 2025tracxn.com
• Gigasundisclosedundisclosedtracxn.com
• Feedzaiundisclosedundisclosedtracxn.com
• Softonicundisclosedundisclosedtracxn.com

Key people

Named individuals at the firm. We don't expose direct email or phone — use their LinkedIn for outreach.

• Josep Ma Echarri · CEO & Managing Partner
• César Rodríguez · Team Member
  LinkedIn
• Gerardo Redondo · Team Member
  LinkedIn
• Josep Maria Echarri · Founder & Managing Partner
• Ignacio Fonts · Managing Partner
• Sergi Audivert · Partner

Sources

• Inveready — Ready for the Future
• Inveready - Crunchbase Company Profile
• Inveready | Investor Profile, Funding Criteria & Team
• Inveready Asset Management investment portfolio | PitchBook
• Inveready - 2025 Investor Profile | Tracxn
• Inveready | LinkedIn
• Martina Milà LinkedIn — Inveready activity
• Gerardo Redondo — Inveready | LinkedIn
• Inveready | Institution Profile | Private Equity International

Other VCs in Spain

• Seaya Ventures · Multi-stage VC, Madrid·
• Kibo Ventures · Multi-stage VC, Madrid·
• K Fund · Early-stage VC, Madrid·
• JME Ventures · Early-stage VC, Madrid·
• Samaipata · Early-stage VC, Madrid + Paris·
• Nauta Capital · B2B VC, Barcelona + London

Explore VCs by sector

• Biotech in Spain
• Enterprise software in Spain

Globally

• Biotech worldwide
• Enterprise software worldwide

Frequently asked